Irinotecan/Oxaliplatin/5-Fluorouracil/Leucovorin/Cetuximab As First Line Treatment In Colorectal Cancer

NCT00689624 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Irinotecan
DRUG: Leukovorin
DRUG: Oxaliplatin
DRUG: 5-FLUOROURACIL
DRUG: Cetuximab

Sponsor

University Hospital of Crete